(1)
Kurniawan, J.; Handayu, A. D.; Aprilicia, G.; Bahri, D. R.; Hasan, I. Resistance-Associated Substitutions (RAS) and Clinical Factors As Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients. Acta Med Indones 2025, 56, 451.